- Home
- CALC vs GROW Comparison
CALC vs GROW Comparison
Compare CALC & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- GROW
- Stock Information
- Founded
- CALC 2011
- GROW 1968
- Country
- CALC United States
- GROW United States
- Employees
- CALC N/A
- GROW N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- CALC Health Care
- GROW Finance
- Exchange
- CALC Nasdaq
- GROW Nasdaq
- Market Cap
- CALC 22.9M
- GROW 31.8M
- IPO Year
- CALC N/A
- GROW N/A
- Fundamental
- Price
- CALC $1.60
- GROW $2.55
- Analyst Decision
- CALC Strong Buy
- GROW
- Analyst Count
- CALC 3
- GROW 0
- Target Price
- CALC $16.33
- GROW N/A
- AVG Volume (30 Days)
- CALC 28.4K
- GROW 29.7K
- Earning Date
- CALC 08-11-2025
- GROW 05-08-2025
- Dividend Yield
- CALC N/A
- GROW 3.52%
- EPS Growth
- CALC N/A
- GROW N/A
- EPS
- CALC N/A
- GROW 0.01
- Revenue
- CALC N/A
- GROW $8,932,000.00
- Revenue This Year
- CALC N/A
- GROW N/A
- Revenue Next Year
- CALC N/A
- GROW N/A
- P/E Ratio
- CALC N/A
- GROW $240.94
- Revenue Growth
- CALC N/A
- GROW N/A
- 52 Week Low
- CALC $1.42
- GROW $2.02
- 52 Week High
- CALC $5.97
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- CALC 32.78
- GROW 75.16
- Support Level
- CALC $1.48
- GROW $2.42
- Resistance Level
- CALC $1.79
- GROW $2.58
- Average True Range (ATR)
- CALC 0.12
- GROW 0.07
- MACD
- CALC -0.02
- GROW 0.01
- Stochastic Oscillator
- CALC 0.00
- GROW 85.71
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.